Health Care [ 8/12 ] | Pharmaceuticals [ 40/73 ]
NASDAQ | Common Stock
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases.
The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases.
Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases.
The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023.
KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 12, 25 | -1.74 Increased by +58.44% | -2.54 Increased by +31.44% |
| Mar 27, 25 | -1.23 Increased by +61.27% | -2.47 Increased by +50.14% |
| Nov 11, 24 | -1.93 Increased by +43.28% | -2.43 Increased by +20.41% |
| Aug 6, 24 | -3.16 Increased by +27.52% | -4.40 Increased by +28.18% |
| May 14, 24 | -4.19 Increased by +40.06% | -2.89 Decreased by -44.98% |
| Mar 29, 24 | -3.18 Increased by +60.10% | -3.62 Increased by +12.15% |
| Nov 13, 23 | -3.41 Decreased by -117.71% | -2.15 Decreased by -58.60% |
| Aug 4, 23 | -4.36 Increased by +77.05% | -3.19 Decreased by -36.68% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 0.00 Decreased by N/A% | -8.95 M Increased by +24.22% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by -100.00% | -8.18 M Increased by +5.24% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -8.95 M Decreased by -2.83% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -9.58 M Increased by +8.01% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -11.81 M Increased by +18.32% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 70.00 K Decreased by -94.30% | -8.63 M Increased by +37.76% | Decreased by -12.32 K% Decreased by -991.94% |
| Sep 30, 23 | 0.00 Decreased by -100.00% | -8.70 M Decreased by -129.94% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by -100.00% | -10.41 M Increased by +61.81% | Decreased by N/A% Decreased by N/A% |